Assessing the Pharmacological Potential of Thymoquinone for Managing Alcohol Craving and Withdrawal Syndrome in Mice
1, 2, 1
- 1Department of Pharmacology, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Punjab, INDIA.
- 2Department of Pharmaceutics, Azad College of Pharmacy, Peddamangalaram, Moinabad, Hyderabad, Telangana, INDIA.
CORRESPONDENCE
Dr. Navneet Khurana
Department of Pharmacology, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-144411, Punjab, INDIA.
Received: 27-06-2024; Revised: 22-08-2024; Accepted: 14-11-2024.
Volume 59, Issue 1 · pp. 101-111 · 2025 · DOI: 10.5530/ijper.20250194
ABSTRACT
Aim/Background: The aim is to evaluate THMQ's impact on alcohol withdrawal and alcohol craving using an animal model. Mice were exposed to increasing ethanol doses to simulate dependency. Researchers assessed anxiety levels during withdrawal using behavioural and biochemical tests. THMQ was administered orally at 20 mg/kg and 40 mg/kg, compared to diazepam (1 mg/kg).Materials and Methods: Model Creation Mice received escalating ethanol doses (5% to 35% v/v) over specific days. Regular water was given during withdrawal periods. Assessment Tools Elevated Plus Maze (EPM), Elevated Zero Maze (EZM), Open Field Test (OFT), and Western Blot analysis. Treatment Intervention: THMQ (20 mg/kg and 40 mg/kg) vs. diazepam (1 mg/kg). Results and Conclusion: THMQ-treated group showed reduced anxiety and alcohol desire. Alcohol consumption decreased in THMQ-treated mice. No changes in GluA1 and sk2 protein levels. THMQ holds promise as a remedy for alcohol cravings and withdrawal symptoms
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sarmad, M. A., Ramana, M. V., & Khurana, N. (2025). Assessing the Pharmacological Potential of Thymoquinone for Managing Alcohol Craving and Withdrawal Syndrome in Mice. Indian Journal of Pharmaceutical Education and Research, 59(1), 101-111. https://doi.org/10.5530/ijper.20250194
Copyright and licence
© 2025 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0